论文部分内容阅读
目的:对五水头孢唑林钠和头孢唑林钠用于小儿支气管肺炎的临床治疗效果进行对比分析。方法:选取我院在2011年2月-2013年2月间收治的100例小儿支气管肺炎患者,随机、平均分为对照组与实验组(各50例),为对照组患儿提供头孢唑林钠药物治疗,为实验组患儿提供五水头孢唑林钠药物治疗,在一定周期后,对两组患儿的病症恢复情况进行对比分析。结果:与对照组相比,实验组患儿咳嗽、流涕、发热及肺部啰音等症状消减情况明显较好[对照组治疗效率为72.0%(36/50),实验组治疗效率为92%(46/50)],且治疗所需时长显著减少;另外,实验组患儿不良症状发生机率较低。两种药物临床治疗效果存在显著性差异(P<0.05)。结论:与头孢唑林钠相比,五水头孢唑林钠对于小儿支气管肺炎临床治疗效果更好,药物安全性较高,更适合用于临床医学治疗。
Objective: To compare the clinical effects of cefazolin sodium pentafluoride and cefazolin sodium in children with bronchopneumonia. Methods: A total of 100 children with bronchopneumonia treated in our hospital from February 2011 to February 2013 were randomly divided into control group and experimental group (50 cases in each group), and the control group was given cefazolin Sodium drug treatment for the experimental group to provide five water cefazolin sodium drug treatment, after a certain period, the two groups of children’s illness recovery comparison. Results: Compared with the control group, the reduction of symptoms such as cough, runny nose, fever and pulmonary rales in the experimental group was significantly better [the control group was 72.0% (36/50), and the experimental group was 92 % (46/50)], and the time required for treatment was significantly reduced; In addition, the incidence of adverse symptoms in children with experimental group was lower. There was significant difference between the two drugs in clinical treatment (P <0.05). CONCLUSION: Compared with cefazolin sodium, cefazolin sodium pentahydrate is more effective in clinical treatment of children with bronchopneumonia and has higher drug safety and is more suitable for clinical treatment.